The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Fried, Frank, Harris, Shriver & Jacobson LLP

801, 17TH STREET, NW, WASHINGTON, DC 20006, USA
Tel:
Work +1 202 639 7000
Fax:
Fax +1 202 639 7003
Email:
Web:
www.friedfrank.com
Frankfurt, London, New York, Washington DC

James Anklam

Tel:
Work +1.202.639.7042
Email:
Fried, Frank, Harris, Shriver & Jacobson LLP

Position

James E. Anklam is a litigation partner, resident in Fried Frank’s Washington, DC office. His practice focuses on defending clients in securities litigations and government investigations, including matters arising under the Foreign Corrupt Practices Act (“FCPA”). In addition, Mr. Anklam regularly defends clients in shareholder derivative litigations and represents clients in complex commercial disputes.

Career

Following law school, Mr. Anklam completed a one-year judicial clerkship for the Honorable James L. Buckley of the US Court of Appeals for the District of Columbia Circuit.

Education

Mr. Anklam received his JD, magna cum laude from Cornell Law School in 1987, and was a member of the Order of the Coif. He also served as the Symposium Editor for the Cornell Law Review. Mr. Anklam received his BA from the University of Virginia in 1981.


United States: Dispute resolution

Securities litigation - defense

Within: Securities litigation - defense

Fried, Frank, Harris, Shriver & Jacobson LLP has a busy securities litigation practice in New York and Washington DC, and last year it handled litigation matters for some of the firm's largest corporate clients, including UnderArmour, Perrigo and Xerox. For UnderArmour, James Wareham in DC and Samuel Groner in New York secured the dismissal of a consolidated class action in which it was claimed that its officers made material misstatements regarding the company’s performance and future prospects, including allegations that it had failed to report declining consumer demand for its products. For pharmaceuticals company Perrigo, Wareham and DC-based James Anklam defended a 10b5 class action in which plaintiffs allege that the company's stock price fell due to, inter alia, overstatement of organic growth in the company and failure to disclose problems with the integration of Omega Pharma Invest. Other recommended partners in New York include Stephen JurisIsrael David and Scott Luftglass.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to